Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
G Ital Nefrol ; 32(3)2015.
Article in Italian | MEDLINE | ID: mdl-26093135

ABSTRACT

Vascular calcifications in uremic patients are associated with a significant increase in cardiovascular morbidity and mortality. Sodium thiosulfate (STS) has been shown to reduce the progression of uremic calcifications in haemodialysis patients. In our study we evaluated the effects on evolution of aortic calcifications of the drug infused during the last 2 hours of dialysis sessions at a dose of 10 grams. 18 hemodialysis patients were evaluated as regards the calcifications index according to Kauppila, calcium-phosphorus metabolism, PTH, and oral chelation therapy. The side effects of STS and the symptomatic effects reported by the patient, were also evaluated using a questionnaire delivered to patients. After 6 months of therapy, a modest reduction of the Kauppila's index (from 16.4 5.5 to 15.1 4.6) was detected. No significant change was detected in blood tests. Even chelation therapy did not suffer variations. It was also showed a clear and statistically significant improvement in signs and symptoms of leg pain, a moderate improvement of' power reserve and a reduction of muscle fatigue. The results of our study, although preliminary and on a small number of patients, confirm a positive effect of STS on vasculopatic symptoms and progression of vascular calcifications.


Subject(s)
Chelating Agents/therapeutic use , Renal Dialysis , Thiosulfates/therapeutic use , Vascular Calcification/drug therapy , Female , Humans , Male , Middle Aged , Treatment Outcome
2.
J Stroke Cerebrovasc Dis ; 18(5): 329-35, 2009.
Article in English | MEDLINE | ID: mdl-19717014

ABSTRACT

OBJECTIVE: We analyzed patients with stroke in a neurorehabilitation unit to define incidence of dysphagia, compare clinical bedside assessment and videofluoroscopy (VFS), and define any correlation between dysphagia and clinical characteristic of patients. METHODS: In all, 151 consecutive inpatients with recent ischemic or hemorrhagic stroke were enrolled. RESULTS: Dysphagia was clinically diagnosed in 62 of 151 patients (41%). A total of 49 patients (79% of clinically dysphagic patients) underwent VFS. Six patients clinically suggested to be dysphagic had a normal VFS finding. The correlation between clinical and VFS diagnosis of dysphagia was significant (r = 0.6505). Penetrations and aspirations were observed, respectively, in 42.8% and 26.5% of patients with dysphagia, with 12.2% classified as silent. Lower respiratory tract infections were observed in 5.9%, more frequently in patients with dysphagia (30%). Dysphagia was not influenced by type of stroke. Cortical stroke of nondominant side was associated with dysphagia (P = .0322) and subcortical nondominant stroke showed a reduced frequency of dysphagia (P = .0008). Previous cerebrovascular disease resulted associated to dysphagia (P = .0399). Patients with dysphagia had significantly lower functional independence measurement (FIM) and level of cognitive functioning on admission and lower FIM on discharge, longer hospital stay, and more frequent malnutrition, and they were more frequently aphasic and dysarthric. Percutaneous endoscopic gastrostomy was used in 18 of 151 patients (11.9%) (41.8% of patients with VFS-proved dysphagia). CONCLUSIONS: Dysphagia occurs in more than a third of patients with stroke admitted to rehabilitation. Clinical assessment demonstrates good correlation with VFS. The grade of dysphagia correlates with dysarthria, aphasia, low FIM, and level of cognitive functioning. Large cortical strokes of nondominant side are associated with dysphagia.


Subject(s)
Deglutition Disorders/diagnosis , Deglutition Disorders/epidemiology , Rehabilitation Centers/statistics & numerical data , Stroke/epidemiology , Stroke/pathology , Activities of Daily Living , Aged , Aged, 80 and over , Aphasia/epidemiology , Cerebrum/pathology , Cerebrum/physiopathology , Cognition Disorders/epidemiology , Comorbidity , Deglutition Disorders/rehabilitation , Disability Evaluation , Dominance, Cerebral/physiology , Dysarthria/epidemiology , Female , Fluoroscopy , Gastrostomy/statistics & numerical data , Humans , Incidence , Length of Stay , Male , Malnutrition/epidemiology , Middle Aged , Pneumonia, Aspiration/epidemiology , Predictive Value of Tests , Severity of Illness Index , Stroke/physiopathology
3.
Am J Ind Med ; 50(8): 577-83, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17620282

ABSTRACT

BACKGROUND: Silicosis is caused by inhaling free crystalline silica. Few case reports have addressed the risk of silicosis in the jewelry trade where chalk molds containing a high percentage of silica are used in casting. We conducted a cross-sectional study involving 100 goldsmiths exposed to silica. METHODS: All workers replied to a questionnaire and underwent a clinical examination, pulmonary function tests, a chest X-ray and a high-resolution CT scan. RESULTS: High-resolution CT visualized signs of silicosis in 23 cases, confirmed by standard chest X-rays in 10. In the 23 workers with CT evidence of silicosis Total Lung Capacity, FEV1 and the Lung Diffusing Capacity did not differ from the workers without the disease. Pulmonary function tests did not correlate with silica exposure. CONCLUSION: In this study we demonstrate that use of chalk molds in casting in jewelry causes silicosis. The composition of the dust could be responsible of the high prevalence observed.


Subject(s)
Metallurgy , Occupational Exposure , Silicon Dioxide/adverse effects , Silicosis/diagnosis , Silicosis/epidemiology , Adult , Cross-Sectional Studies , Female , Forced Expiratory Volume , Humans , Italy/epidemiology , Male , Middle Aged , Prevalence , Surveys and Questionnaires , Tomography, X-Ray Computed , Total Lung Capacity
SELECTION OF CITATIONS
SEARCH DETAIL
...